��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Impact of co-morbid amyloid pathology on clinical phenotype of patients with vascular cognitive impairment

Topic Aging and Dementia

Presentation(s) P2 - (-)

Poster/Presentation
Number 099

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
David Bergeron (Universite Laval) PRESENTER	No disclosure on file
Niels D. Prins, MD (Brain Research Center)	Dr. Prins has stock in Brain Research Center. Dr. Prins has received personal compensation in the range of $100,000-$499,999 for serving as a CEO with Brain Research Center.
	No disclosure on file
	No disclosure on file
Robert Laforce, Jr., MD, PhD (CHU De Quebec)	Dr. Laforce has nothing to disclose.
	No disclosure on file
Frederik Barkhof, MD, PhD (Image Analysis Center)	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
	No disclosure on file
Philip Scheltens, MD, PhD, FAAN (Alzheimer Center Amsterdam University medical Center)	Dr. Scheltens has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVO NOrdisk.
	No disclosure on file